Institutional & Family Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15
Closed -$554 752
2023
Q4
$554 Hold
15
﹤0.01% 664
2023
Q3
$573 Hold
15
﹤0.01% 657
2023
Q2
$541 Sell
15
-16
-52% -$546 ﹤0.01% 675
2023
Q1
$1.18K Hold
31
﹤0.01% 612
2022
Q4
$1.76K Hold
31
﹤0.01% 563
2022
Q3
$1K Hold
31
﹤0.01% 636
2022
Q2
$1K Hold
31
﹤0.01% 654
2022
Q1
$1K Buy
31
+5
+19% +$178 ﹤0.01% 694
2021
Q4
$1K Sell
26
-4
-13% -$149 ﹤0.01% 719
2021
Q3
$1K Sell
30
-22
-42% -$920 ﹤0.01% 837
2021
Q2
$2K Buy
52
+10
+24% +$443 ﹤0.01% 820
2021
Q1
$2K Sell
42
-25
-37% -$1.14K ﹤0.01% 792
2020
Q4
$3K Sell
67
-2
-3% -$72 ﹤0.01% 703
2020
Q3
$2K Buy
69
+24
+53% +$668 ﹤0.01% 698
2020
Q2
$1K Sell
45
-13
-22% -$293 ﹤0.01% 778
2020
Q1
$1K Hold
58
﹤0.01% 741
2019
Q4
$1K Hold
58
﹤0.01% 811
2019
Q3
$1K Buy
+58
New +$955 ﹤0.01% 784

Other funds holding HALO

Institutional & Family Asset Management's HALO Position: Q1 2024 in Review

Institutional & Family Asset Management sold out of Halozyme (HALO) in Q1 2024, closing a stake of 15 shares — an estimated $554 sold.

Institutional & Family Asset Management first reported a position in HALO in Q3 2019 and held it in 18 quarters. The position peaked at $3K in Q4 2020. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Institutional & Family Asset Management reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Institutional & Family Asset Management sold 15 Halozyme shares in Q1 2024, an estimated $554.
  • Institutional & Family Asset Management first reported a position in Halozyme in Q3 2019 and held it in 18 quarters.
  • Institutional & Family Asset Management's Halozyme position peaked at $3K in Q4 2020.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Institutional & Family Asset Management's 13F filing for Q1 2024, filed 8 May 2024.